Sandoz Reveals New Headquarters Post Spin, Mid-2024 Date Outlined
Separation From Parent Novartis Planned For H2 2023
Executive Summary
Tracing its roots back to Basel in the late nineteenth century, Sandoz has confirmed the location of its new planned permanent headquarters post-spin.
You may also be interested in...
Generics Bulletin Explains: Sandoz’s Spinoff From Novartis
Ahead of a Sandoz capital markets day on 8 June, Generics Bulletin explains what we know so far about the firm’s spinoff from parent company Novartis – as well as the questions that the companies are yet to answer.
Sandoz Names Board Ahead Of Novartis Spinoff
As Sandoz moves closer to being spun off from parent company Novartis, the generics and biosimilars firm has revealed the structure and membership of its board under chair Gilbert Ghostine.
Novartis Hikes Sandoz Sales Guide As Separation Edges Closer
Novartis reported 8% top-line growth for its Sandoz unit during the first quarter of 2023, one of the last before it is separated into a standalone company.